Cargando…

A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia

Relapse and acquired drug resistance in T-cell acute lymphoblastic leukemia (T-ALL) remains a significant clinical problem. This study was designed to establish a preclinical model of resistance to induction therapy in childhood T-ALL to examine the emergence of drug resistance and identify novel th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samuels, A L, Beesley, A H, Yadav, B D, Papa, R A, Sutton, R, Anderson, D, Marshall, G M, Cole, C H, Kees, U R, Lock, R B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219466/ https://www.ncbi.nlm.nih.gov/pubmed/25083816 http://dx.doi.org/10.1038/bcj.2014.52

Ejemplares similares

Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia
por: Yadav, Babasaheb D., et al.
Publicado: (2016)

Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia
por: Samuels, Amy L, et al.
Publicado: (2010)

Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia
por: Beesley, Alex H, et al.
Publicado: (2010)

The evolution of clinical trials for infant acute lymphoblastic leukemia
por: Kotecha, R S, et al.
Publicado: (2014)

Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
por: Beesley, A H, et al.
Publicado: (2010)

Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
por: Beesley, A H, et al.
Publicado: (2009)

Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study
por: Cleaver, Amanda L, et al.
Publicado: (2010)

The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution
por: Anderson, Denise, et al.
Publicado: (2020)

Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell‐free DNA
por: Kumar, Rahul, et al.
Publicado: (2021)

Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts
por: Szymanska, Barbara, et al.
Publicado: (2012)

Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines
por: Beesley, A H, et al.
Publicado: (2006)

Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
por: Cruickshank, M N, et al.
Publicado: (2017)

Cerebral aspergillus infection in pediatric acute lymphoblastic leukemia induction therapy
por: Prakash, Gaurav, et al.
Publicado: (2012)

Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia
por: Alruwetei, Abdulmohsen M., et al.
Publicado: (2020)

Targeting survivin and p53 in pediatric acute lymphoblastic leukemia
por: Tyner, J W, et al.
Publicado: (2012)

Bone Marrow Recovery by Morphometry during Induction Chemotherapy for Acute Lymphoblastic Leukemia in Children
por: Nguyen, Tuong-Vi, et al.
Publicado: (2015)

Acute Hepatitis A Induction of Precursor B-Cell Acute Lymphoblastic Leukemia: A Causal Relationship?
por: Senadhi, V., et al.
Publicado: (2010)

Post covid primary cutaneous mucormycosis in pediatric acute lymphoblastic leukemia induction - Case report
por: Annapoorani, A., et al.
Publicado: (2021)

Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2012)

Correction: Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2012)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.
por: Anderson, H., et al.
Publicado: (1984)

Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes
por: Loganathan, Ajeitha, et al.
Publicado: (2022)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2023)

Leukemia cutis in a patient with pre–B-cell acute lymphoblastic leukemia
por: Campuzano-García, Andrés Eduardo, et al.
Publicado: (2015)

Cutaneous Leishmaniasis in an Immunocompromised Pediatric Patient With Acute Lymphoblastic Leukemia
por: Cohen, Stephanie R, et al.
Publicado: (2021)

Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia
por: Du, Xin, et al.
Publicado: (2017)

Encephalopathy and brain atrophy during induction chemotherapy in acute lymphoblastic leukemia
por: Li, Qiao‐Ru, et al.
Publicado: (2020)

The Effect of Chemotherapy Induction Therapy on the Pancreas in Patients with Acute Lymphoblastic Leukemia
por: Wondmeneh, Temesgen Gebeyehu, et al.
Publicado: (2022)

The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia
por: O'Connor, David, et al.
Publicado: (2023)

GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy
por: Heidari, N, et al.
Publicado: (2010)

The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia
por: Dander, Erica, et al.
Publicado: (2021)

Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression
por: McClure, Barbara J., et al.
Publicado: (2018)

Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia
por: van der Veer, A, et al.
Publicado: (2014)

Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia
por: Richter-Pechańska, P, et al.
Publicado: (2017)

The Successful Implementation of a Modified Pediatric Acute Lymphoblastic Leukemia Protocol to Treat an Elderly Patient With T-cell Lymphoblastic Leukemia: A Case Report
por: Motabi, Ibraheem H, et al.
Publicado: (2023)

Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
por: Pellegrini, Paola, et al.
Publicado: (2020)

High expression of Myosin 1g in pediatric acute lymphoblastic leukemia
por: Estrada-Abreo, Laura A., et al.
Publicado: (2021)

Characterization of Philadelphia-like Pre-B Acute Lymphoblastic Leukemia: Experiences in Mexican Pediatric Patients
por: Martínez-Anaya, Daniel, et al.
Publicado: (2022)

Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients
por: Abdel-azim, Nivin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j50gafcok0e5qi6u8mvkoo71o9